C. Lambert (Liège, Belgium)

University of Liège Bone and Cartilage Research Unit

Author Of 3 Presentations

 Conference Calendar
Podium Presentation Osteoarthritis

26.2.7 - Glucosepane: A New Biomarker Of The Severity Of Osteoarthritis (ID 9445)

Presentation Number
26.2.7
Topic
Osteoarthritis
Lecture Time
11:24 - 11:33
Session Name
26.2 - Proteomics / Biomarkers / Epigenetics (ID 843)
Corresponding Author
Authors
Disclosure
No Significant Commercial Relationships
Poster Osteoarthritis

P196 - Osteoblasts Secretome Analysis Provides new Insights in Mechanisms Underlying Osteoarthritis Subchondral Bone Sclerosis (ID 9415)

Presentation Number
P196
Topic
Osteoarthritis
Lecture Time
10:45 - 10:45
Session Name
11.0 - Poster Viewing / Exhibition (ID 780)
Corresponding Author
Authors
Disclosure
No Significant Commercial Relationships
Poster Osteoarthritis

P197 - The Coll2-1 Peptide of Collagen Type II: A New Actor of Synovitis in Osteoarthritis (ID 9429)

Presentation Number
P197
Topic
Osteoarthritis
Lecture Time
10:45 - 10:45
Session Name
11.0 - Poster Viewing / Exhibition (ID 780)
Corresponding Author
Authors
Disclosure
No Significant Commercial Relationships

Presenter Of 1 Presentation

 Conference Calendar
Poster Osteoarthritis

P197 - The Coll2-1 Peptide of Collagen Type II: A New Actor of Synovitis in Osteoarthritis (ID 9429)

Presentation Number
P197
Topic
Osteoarthritis
Lecture Time
10:45 - 10:45
Session Name
11.0 - Poster Viewing / Exhibition (ID 780)
Corresponding Author
Authors
Disclosure
No Significant Commercial Relationships

Poster Author Of 2 e-Posters

 ePosters
Osteoarthritis

P196 - Osteoblasts Secretome Analysis Provides new Insights in Mechanisms Underlying Osteoarthritis Subchondral Bone Sclerosis (ID 9415)

Authors
Corresponding Author
Disclosure
No Significant Commercial Relationships
Topic
Osteoarthritis
Rating
 Not Rated
Osteoarthritis

P197 - The Coll2-1 Peptide of Collagen Type II: A New Actor of Synovitis in Osteoarthritis (ID 9429)

Authors
Corresponding Author
Disclosure
No Significant Commercial Relationships
Topic
Osteoarthritis
Rating
 5